| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |